In the human genome over 500 proteases have been discovered having a wide variety of functions. Also pathogenic viruses and microorganisms may have proteases involved in infectivity, growth or virulence. Therefore proteases have drawn considerable attention as potential targets for therapeutic intervention.

To aid drug discovery and development QuickZyme BioSciences offers:

• custom screening assay development
• medium throughput screening services and hit validation services based on its proprietary
• QuickZyme technology platform, or on generic technology
• IC50 or Ki determinations

QuickZyme biosciences builds on a long experience of research on proteolytic enzymes and assays in the field of coagulation, fibrinolysis, tumor biology and bone- and cartilage degradation and has distinguished pharmaceutical, biotech and life science companies as its customers.